Vanda Pharmaceuticals
VNDA
$7.46
Share price
1.96%
Change (1 day)
17.94%
Change (1 year)
Categories
Vanda Pharmaceuticals (VNDA) - Cash on Hand
Cash on Hand as of December 2024 : A$0.59 Billion
According to Vanda Pharmaceuticals's latest financial reports the company has A$0.59 Billion in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Vanda Pharmaceuticals - Cash on Hand chart (from 2005 to 2024)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2024-12-31 | A$0.60 B | 5.69% |
| 2023-12-31 | A$0.56 B | -16.93% |
| 2022-12-31 | A$0.68 B | 14.92% |
| 2021-12-31 | A$0.59 B | 24.83% |
| 2020-12-31 | A$0.47 B | 7.28% |
| 2019-12-31 | A$0.44 B | 22.03% |
| 2018-12-31 | A$0.36 B | 98.87% |
| 2017-12-31 | A$0.18 B | -6.32% |
| 2016-12-31 | A$0.19 B | -0.24% |
| 2015-12-31 | A$0.19 B | 23.9% |
| 2014-12-31 | A$0.15 B | 8.55% |
| 2013-12-31 | A$0.14 B | 26.13% |
| 2012-12-31 | A$0.11 B | -20.21% |
| 2011-12-31 | A$0.14 B | -25.52% |
| 2010-12-31 | A$0.19 B | -14.69% |
| 2009-12-31 | A$0.22 B | 247.05% |
| 2008-12-31 | A$65.84 M | -32.41% |
| 2007-12-31 | A$97.42 M | 140.96% |
| 2006-12-31 | A$40.42 M | -5.04% |
| 2005-12-31 | A$42.57 M | 102.64% |
| 2004-12-31 | A$21.01 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 | A$21.22 B | 3,463.66% | 🇨🇭 Switzerland |
 | A$5.44 B | 813.72% | 🇺🇸 USA |
 | A$38.98 B | 6,445.43% | 🇺🇸 USA |
 | A$17.26 B | 2,798.49% | 🇺🇸 USA |
 | A$32.55 B | 5,365.74% | 🇺🇸 USA |
 | A$5.4 M | -99.09% | 🇺🇸 USA |
 | A$21.76 B | 3,553.88% | 🇺🇸 USA |